Literature DB >> 620099

Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.

M Kirpekar, S M Kirpekar, J C Prat.   

Abstract

1 The effect of tetraethylammonium (TEA) and 4-aminopyridine (4-AP) on the inhibitory effect of guanethidine on noradrenaline (NA) release was investigated in the perfused spleen of the cat. 2 Guanethidine blocked the release of NA evoked by nerve stimulation. TEA and 4-AP readily reversed this inhibitory effect, and the NA output was nearly doubled after repeated stimulation of the nerves. On subsequent perfusion with Krebs solution without TEA or 4-AP, the inhibitory effect of guanethidine reappeared. 3 The reversal of guanethidine blockade of sympathetic nerves by TEA and 4-AP is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620099      PMCID: PMC1667782          DOI: 10.1111/j.1476-5381.1978.tb07008.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Potentiation by tetraethylammonium of the response of the cat spleen to postganglionic sympathetic nerve stimulation.

Authors:  H Thoenen; W Haefely; H Staehelin
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

3.  On the mechanism of the adrenergic nerve blocking action of bretylium.

Authors:  G Haeusler; W Haefely; A Huerlimann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

4.  Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanthidine.

Authors:  S M Kirpekar; A R Wakade; W Dixon; J C Prat
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

5.  Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.

Authors:  H Thoenen; A Huerlimann; W Haefely
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

6.  Effect of tetraethylammonium and barium on the release of noradrenaline from the perfused cat spleen by nerve stimulation and potassium.

Authors:  S M Kirpekar; A R Wakade; J C Prat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

7.  The action of tetraethyl-ammonium chloride on the response of the rat anococcygeus muscle to motor and inhibitory nerve stimulation and to some drugs.

Authors:  J S Gillespie; A K Tilmisany
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

8.  Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.

Authors:  S M Kirpekar; Y Misu
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

9.  Spontaneous and evoked activity of motor nerve endings in calcium Ringer.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

10.  Modification of the evoked release of noradrenaline from the perfused cat spleen by various ions and agents.

Authors:  S M Kirpekar; J C Prat; M Puig; A R Wakade
Journal:  J Physiol       Date:  1972-03       Impact factor: 5.182

View more
  3 in total

1.  Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.

Authors:  J L Berry; R C Small; R W Foster
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Inhibition by adrenergic neurone blocking agents of the relaxation induced by BRL 38227 in vascular, intestinal and uterine smooth muscle.

Authors:  J L Berry; R C Small; S J Hughes; R D Smith; A J Miller; M Hollingsworth; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

3.  Effect of guanidine on release of noradrenaline from the perfused spleen of the cat.

Authors:  J Hirsch; S M Kirpekar; J C Prat
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.